My HPRA: Register

GALLIVAC IB88

4.0-5.3 log 10 50% embryo infective dose/dose Powder for nebuliser suspension

Merial Animal Health LimitedVPA10857/051/001

Main Information

Trade NameGALLIVAC IB88
Active SubstancesLive attenuated infectious bronchitis coronavirus, (strain CR88121) (793B)
Strength4.0-5.3 log 10 50% embryo infective dose/dose
Dosage FormPowder for nebuliser suspension
Licence HolderMerial Animal Health Limited
Licence NumberVPA10857/051/001

Group Information

ATC CodeQI01AD07 avian infectious bronchitis virus
Therapeutic ClassImmunological - Live Vaccine
SpeciesChickens

Status

Authorised/WithdrawnAuthorised
Licence Issued23/06/2003
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back
Follow medicine

Print

Summary of Product Characteristics

View More SPC Headings

Latest Changes to Medicine Info & SPC

View all available

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.